Automate Your Wheel Strategy on PODD
With Tiblio's Option Bot, you can configure your own wheel strategy including PODD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PODD
- Rev/Share 33.549
- Book/Share 20.8019
- PB 16.4193
- Debt/Equity 0.9689
- CurrentRatio 2.2345
- ROIC 0.1209
- MktCap 24041150525.0
- FreeCF/Share 5.5823
- PFCF 61.2357
- PE 101.7357
- Debt/Assets 0.4086
- DivYield 0
- ROE 0.1843
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Resumed | PODD | Oppenheimer | -- | Outperform | -- | $365 | Sept. 8, 2025 |
| Initiation | PODD | Truist | -- | Buy | -- | $365 | June 16, 2025 |
| Initiation | PODD | Goldman | -- | Buy | -- | $380 | May 30, 2025 |
| Upgrade | PODD | Wolfe Research | Peer Perform | Outperform | -- | $350 | May 13, 2025 |
| Downgrade | PODD | Wolfe Research | Outperform | Peer Perform | -- | -- | April 29, 2025 |
| Initiation | PODD | RBC Capital Mkts | -- | Outperform | -- | $340 | March 6, 2025 |
News
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Insulet unveils positive RADIANT trial clinical data for its Omnipod 5 at the 18th international conference on ATTD.
Read More
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst
Published: February 21, 2025 by: Benzinga
Sentiment: Positive
On Thursday, Insulet Corporation PODD reported fourth-quarter adjusted EPS of $1.15, down from $1.40 a year ago but beating the consensus of $1.02.
Read More
Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral
Insulet Corporation (NASDAQ:PODD ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants June Lazaroff - Senior Director of Investor Relations Jim Hollingshead - President & Chief Executive Officer Ana Chadwick - Executive Vice President, Chief Financial Officer & Treasurer Conference Call Participants Robert Marcus - JPMorgan Jeffrey Johnson - Baird Travis Steed - Bank of America Michael Polark - Wolfe Research Issie Kirby - Redburn Atlantic Patrick Wood - Morgan Stanley Macauley Kilbane - William Blair Larry Biegelsen - Wells Fargo Marie Thibault - BTIG Mike Kratky - Leerink Partners Jayson Bedford - Raymond James …
Read More
About Insulet Corporation (PODD)
- IPO Date 2007-05-15
- Website https://www.insulet.com
- Industry Medical - Devices
- CEO Ashley A. McEvoy
- Employees 3900